DuPont de Nemours

DD on NYSE. DuPont sells materials and chemicals to healthcare, water, construction and industrial customers. Market value $17.6bn.

Watch this stockFree. We tell you when something changes.

Price checks use the past 12 months to June 2026. Quality checks use five annual reports, the latest for the year to December 2025.

The company doesn't report operating profit, so we work it out from pre-tax profit and interest.

Should I look at this?

Not a fit for our list right now

See Industrials stocks that passed both tests

This is not advice. Check the numbers below.

Compare with another stock

Cash yield
past 12 months to June 2026
3.9%fair

For every $100 of what the whole company costs, it produced $3.90 of spare cash in the past 12 months. A savings account pays about $4.

Price to profit
past 12 months to June 2026
27.7×full

You pay 27.7 years of operating profit for the business. The average large US company costs around 18.

Return on capital
five annual reports to December 2025
n/a

The filings do not give us enough to work this out.

Quality score: 56 of 100. Price score: 27 of 100. Our list needs 70 on quality and 60 on price.

$133.28 a share, 44% above its 1-year low

Over the past year the price has ranged from $92.49 to $157.98.

Dividend: 2.3% a year

Paid every year for at least 5 years

Prices from Tuesday’s close (6 October).

Five years of cash, in billions

1.5
-0.1
0.5
0.5
0.2
0.7
2021202220232024202512 monthsto Jun '26

Spare cash swings from quarter to quarter here: $702 million in the past 12 months, $227 million in the year to December 2025.

Revenue
$12.6bn$13.0bn$6.6bn$6.7bn$6.8bn
Operating margin
n/an/an/an/an/a
Debt to equity
0.410.310.320.310.23
Shares outstanding
0.50bn0.43bn0.42bn0.42bn0.14bn

Health checks

  • Free cash flow positive4 of 5 years
  • Accounting looks honest (Beneish)Nothing unusual
  • Financial strength (Piotroski)5 of 8 checks we could run
  • Profit backed by cash (accruals)Yes
  • Debt0.23× equity
  • Revenue growth, five yearsShrinking, 19.6% a year
  • Buying back its own sharesYes, 73% fewer since 2021

The quarter to June 2026

How the business did, compared with the same quarter a year earlier.

  • Sales: $1.8 billion last quarter, up 4% on a year ago.
  • Profit: $143 million, up 142% on a year ago.
  • Spare cash over the past 12 months: $702 million. A year earlier it spent $252 million more than it brought in.
  • 2% fewer shares than a year ago. Each share owns a bit more of the company.
  • Debt is $1.4 billion more than cash, down from $5.3 billion a year ago.
  • Sales grew on a year ago in each of the last 4 quarters.
Sales by quarter
Sales by quarter
Quarter toAmount
September 2024$1.7bn
December 2024$1.7bn
March 2025$1.6bn
June 2025$1.7bn
September 2025$1.8bn
December 2025$1.7bn
March 2026$1.7bn
June 2026$1.8bn
Profit by quarter
Profit by quarter
Quarter toAmount
September 2024$454m
December 2024-$117m
March 2025-$589m
June 2025$59m
September 2025-$123m
December 2025-$126m
March 2026$161m
June 2026$143m

From the company's quarterly reports to the SEC.

Dates

Next results (estimated)
3 November 2026
Last annual report (10-K)
17 February 2026
Next quarterly (estimated, 10-Q)
3 November 2026

Who owns it

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

2 investors own more than 5%.

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

No insider bought shares on the open market in the last 12 months. 2 sold $607,254.

  • Koch Lori
    CEO, Director
    Sold
    Date
    2 June 2026
    Shares
    261
    Price
    $48.82
    Value
    $12,741
  • Hoover Erik T.
    SVP & General Counsel
    Sold
    Date
    28 November 2025
    Shares
    6,005
    Price
    $39.79
    Value
    $238,939
  • Koch Lori
    CEO, Director
    Sold
    Date
    28 November 2025
    Shares
    9,011
    Price
    $39.46
    Value
    $355,574

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

None of the warning signs we check for were found.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 17 Feb 2026, plus the 10-Q filed 4 Aug 2026 and 8 later 8-Ks.

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

What could go wrong

  • Sales have shrunk: 19.6% a year.
  • It isn't cheap on profits: 27.7× operating profit.

Whether the price already reflects the risks is what the deep dive is for.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.